Natural CD4 CD25 FOXP3 regulatory T cells in graftversus-host disease - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 265

[126] Pabst C, Schirutschke H, Ehninger G, Bornhauser M, Platzbecker U. The graft content
of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of
acute graft versus host disease after transplantation of allogeneic peripheral blood stem
cells from unrelated donors. Clin Cancer Res 2007;13:2916-22.
[127] Wolf D, Wolf AM, Fong D, Rumpold H, Strasak A, Clausen J, et al. Regulatory T-cells in
the graft and the risk of acute graft-versus-host disease after allogeneic stem cell trans-
plantation. Transplantation 2007;83:1107-13.
[128] Vela-Ojeda J, Montiel-Cervantes L, Granados-Lara P, Reyes-Maldonado E, Garcia-
Latorre E, Garcia-Chavez J, et al. Role of CD4+CD25+highFoxp3+CD62L+ regulatory
T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplan-
tation. Stem Cells Dev 2010;19:333-40.
[129] Rosenzwajg M, Dhedin N, Maury S, Bensimon G, Landau DA, Norol F, et al. Regulatory
T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.
Biol Blood Marrow Transplant 2011;17:265-9.
[130] Miura Y, Thoburn CJ, Bright EC, Phelps ML, Shin T, Matsui EC, et al. Association of Foxp3
regulatory gene expression with graft-versus-host disease. Blood 2004;104:2187-93.
[131] Magenau JM, Qin X, Tawara I, Rogers CE, Kitko C, Schlough M, et al. Frequency of
CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value
as a biomarker for acute graft-versus-host-disease. Biol Blood Marrow Transplant
2010;16:907-14.
[132] Ukena SN, Grosse J, Mischak-Weissinger E, Buchholz S, Stadler M, Ganser A, et al.
Acute but not chronic graft-versus-host disease is associated with a reduction of circu-
lating CD4(+)CD25 (high)CD127 (low/−) regulatory T cells. Ann Hematol 2011;90:213-8.
[133] Zhai Z, Sun Z, Li Q, Zhang A, Liu H, Xu J, et al. Correlation of the CD4+CD25high
T-regulatory cells in recipients and their corresponding donors to acute GVHD. Trans-
plant Int 2007;20:440-6.
[134] Bremm M, Huenecke S, Lehrnbecher T, Ponstingl E, Mueller R, Heinze A, et al. Advanced
flow cytometric analysis of regulatory T cells: CD127 downregulation early post stem
cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
J Immunol Methods 2011;373:36-44.
[135] Lord JD, Hackman RC, Gooley TA, Wood BL, Moklebust AC, Hockenbery DM, et al.
Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host
disease. Biol Blood Marrow Transplant 2011;17:486-96.
[136] Arimoto K, Kadowaki N, Ishikawa T, Ichinohe T, Uchiyama T. FOXP3 expression in pe-
ripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-
host disease after allogeneic stem cell transplantation. Int J Hematol 2007;85:154-62.
[137] Sanchez J, Casano J, Alvarez MA, Roman-Gomez J, Martin C, Martinez F, et al. Kinetic
of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and
chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Br J Haematol 2004;126:697-703.
[138] Noel G, Bruniquel D, Birebent B, DeGuibert S, Grosset JM, Bernard M, et al. Patients
suffering from acute graft-versus-host disease after bone-marrow transplantation have
functional CD4+CD25hiFoxp3+ regulatory T cells. Clin Immunol 2008;129:241-8.
[139] Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, et al. Reduced frequency
of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host
disease. Blood 2005;106:2903-11.
[140] Matsuoka K, Kim HT, McDonough S, Bascug G, Warshauer B, Koreth J, et al. Altered
regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic
hematopoietic stem cell transplantation. J Clin Invest 2010;120:1479-93.
[141] Meignin V, Peffault de Latour R, Zuber J, Regnault A, Mounier N, Lemaitre F, et al.
Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the estab-
lishment of long-term tolerance after allogeneic stem cell transplantation. Exp Hematol
2005;33:894-900.
[142] Clark FJ, Gregg R, Piper K, Dunnion D, Freeman L, Griffiths M, et al. Chronic graft-
versus-host disease is associated with increased numbers of peripheral blood
CD4+CD25high regulatory T cells. Blood 2004;103:2410-6.
[143] Watanabe N, Narita M, Furukawa T, Nakamura T, Yamahira A, Masuko M, et al. Kinet-
ics of pDCs, mDCs, gammadelta T cells and regulatory T cells in association with graft
versus host disease after hematopoietic stem cell transplantation. Int J Lab Hematol
2011;33:378-90.
[144] Rieger K, Loddenkemper C, Maul J, Fietz T, Wolff D, Terpe H, et al. Mucosal FOXP3+
regulatory T cells are numerically deficient in acute and chronic GvHD. Blood
2006;107:1717-23.
[145] Landfried K, Bataille F, Rogler G, Brenmoehl J, Kosovac K, Wolff D, et al. Recipient
NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host
disease. Clin Exp Immunol 2010;159:87-92.

268